Question 1

What is the catalog number for Clostridium botulinum A Toxoid (Biotin)?

Accepted Answer

The catalog number for Clostridium botulinum A Toxoid (Biotin) is MBS6261477.

Question 2

What sizes are available for Clostridium botulinum A Toxoid (Biotin)?

Accepted Answer

Clostridium botulinum A Toxoid (Biotin) is available in the following size(s): 0.1 mL, 5x 0.1 mL.

Question 3

How many pack sizes does Clostridium botulinum A Toxoid (Biotin) come in?

Accepted Answer

Clostridium botulinum A Toxoid (Biotin) is available in 2 different pack sizes.

Question 4

Is Clostridium botulinum A Toxoid (Biotin) in stock?

Accepted Answer

Clostridium botulinum A Toxoid (Biotin) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 6

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 7

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Clostridium botulinum A Toxoid (Biotin)

Product Specifications

Storage Conditions

Specificity

Short Name

Available Sizes

Frequently Asked Questions

Explore Other Products

PCNA (Proliferating Cell Nuclear Antigen) (G1- & S-phase Marker) (PC5), Biotin conjugate, 0.1mg/mL

Frozen Tissue Sections, Soft tissue

LSM10 (NM_032881) Human Over-expression Lysate

GAPDH Mouse Monoclonal Antibody [Clone ID: 6C5]

Tau (MAPT) (NM_005910) Human Over-expression Lysate

OR9I1 Human Gene Knockout Kit (CRISPR)